Application of mesenchymal stem cells in inflammatory and fibrotic diseases

Cited 30 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorJ S Ryu-
dc.contributor.authorEun-Jeong Jeong-
dc.contributor.authorJ Y Kim-
dc.contributor.authorS J Park-
dc.contributor.authorW S Ju-
dc.contributor.authorC H Kim-
dc.contributor.authorJang Seong Kim-
dc.contributor.authorY K Choo-
dc.date.accessioned2022-04-29T06:20:56Z-
dc.date.available2022-04-29T06:20:56Z-
dc.date.issued2020-
dc.identifier.issn1661-6596-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/25864-
dc.description.abstractMesenchymal stem cells (MSCs) are multipotent stem cells that can be isolated from various tissues in the adult body. MSCs should be characterized by three criteria for regenerative medicine. MSCs must (1) adhere to plastic surfaces, (2) express specific surface antigens, and (3) differentiate into mesodermal lineages, including chondrocytes, osteoblasts, and adipocytes, in vitro. Interestingly, MSCs have immunomodulatory features and secrete trophic factors and immune receptors that regulate the microenvironment in host tissue. These specific and unique therapeutic properties make MSCs ideal as therapeutic agents in vivo. Specifically, pre-clinical and clinical investigators generated inflammatory and fibrotic diseases models, and then transplantation of MSCs into diseases models for therapeutic effects investigation. In this review, we characterize MSCs from various tissues and describe their applications for treating various inflammation and fibrotic diseases.-
dc.publisherMDPI-
dc.titleApplication of mesenchymal stem cells in inflammatory and fibrotic diseases-
dc.title.alternativeApplication of mesenchymal stem cells in inflammatory and fibrotic diseases-
dc.typeArticle-
dc.citation.titleInternational Journal of Molecular Sciences-
dc.citation.number21-
dc.citation.endPage8366-
dc.citation.startPage8366-
dc.citation.volume21-
dc.contributor.affiliatedAuthorEun-Jeong Jeong-
dc.contributor.affiliatedAuthorJang Seong Kim-
dc.contributor.alternativeName유재성-
dc.contributor.alternativeName정은정-
dc.contributor.alternativeName김종엽-
dc.contributor.alternativeName박순주-
dc.contributor.alternativeName주원석-
dc.contributor.alternativeName김창현-
dc.contributor.alternativeName김장성-
dc.contributor.alternativeName추영국-
dc.identifier.bibliographicCitationInternational Journal of Molecular Sciences, vol. 21, no. 21, pp. 8366-8366-
dc.identifier.doi10.3390/ijms21218366-
dc.subject.keywordmesenchymal stem cells (MSCs)-
dc.subject.keywordparacrine factors-
dc.subject.keywordinflammatory disease-
dc.subject.keywordfibrotic disease-
dc.subject.localmesenchymal stem cells-
dc.subject.localMesenchymal stem cell-
dc.subject.localMesenchymal stem cells-
dc.subject.localmesenchymal stem cells (MSCs)-
dc.subject.localparacrine factors-
dc.subject.localInflammatory disease-
dc.subject.localinflammatory disease-
dc.subject.localInflammatory diseases-
dc.subject.localfibrotic disease-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Biotherapeutics Translational Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.